Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Aug;44(8):1750-1756.
doi: 10.2337/dc21-0292. Epub 2021 Jun 14.

Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes

Affiliations
Observational Study

Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes

Julia C Prentice et al. Diabetes Care. 2021 Aug.

Abstract

Objective: Short- and long-term glycemic variability are risk factors for diabetes complications. However, there are no validated A1C target ranges or measures of A1C stability in older adults. We evaluated the association of a patient-specific A1C variability measure, A1C time in range (A1C TIR), on major adverse outcomes.

Research design and methods: We conducted a retrospective observational study using administrative data from the Department of Veterans Affairs and Medicare from 2004 to 2016. Patients were ≥65 years old, had diabetes, and had at least four A1C tests during a 3-year baseline period. A1C TIR was the percentage of days during the baseline in which A1C was in an individualized target range (6.0-7.0% up to 8.0-9.0%) on the basis of clinical characteristics and predicted life expectancy. Increasing A1C TIR was divided into categories of 20% increments and linked to mortality and cardiovascular disease (CVD) (i.e., myocardial infarction, stroke).

Results: The study included 402,043 veterans (mean [SD] age 76.9 [5.7] years, 98.8% male). During an average of 5.5 years of follow-up, A1C TIR had a graded relationship with mortality and CVD. Cox proportional hazards models showed that lower A1C TIR was associated with increased mortality (A1C TIR 0 to <20%: hazard ratio [HR] 1.22 [95% CI 1.20-1.25]) and CVD (A1C TIR 0 to <20%: HR 1.14 [95% CI 1.11-1.19]) compared with A1C TIR 80-100%. Competing risk models and shorter follow-up (e.g., 24 months) showed similar results.

Conclusions: In older adults with diabetes, maintaining A1C levels within individualized target ranges is associated with lower risk of mortality and CVD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study design. T, time.

Similar articles

Cited by

References

    1. American Diabetes Association . 6. Glycemic targets. Diabetes Care 2017;40:S48–S56 - PubMed
    1. U.S. Department of Veterans Affairs . VA/DOD Clinical Practice Guidelines: Management of Diabetes Mellitus in Primary Care. Accessed 17 April 2020. Available from https://www.healthquality.va.gov/guidelines/CD/diabetes/
    1. LeRoith D, Biessels GJ, Braithwaite SS, et al. . Treatment of diabetes in older adults: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab 2019;104:1520–1574 - PMC - PubMed
    1. Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ; Clinical Guidelines Committee of the American College of Physicians . Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Ann Intern Med 2018;168:569–576 - PubMed
    1. Beck RW, Bergenstal RM, Riddlesworth TD, et al. . Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care 2019;42:400–405 - PMC - PubMed

Publication types